Search

Your search keyword '"Khatib, R. A."' showing total 207 results
Start Over Author "Khatib, R. A."
207 results on '"Khatib, R. A."'

1. Lipid-Lowering Therapy Utilization and Dosage Among Patients with Acute Coronary Syndrome Events: A Retrospective Cohort from 12 Community Hospitals

Author

Khatib R, Yeh EJ, Glowacki N, McGuiness CB, Xie H, Wade RL, Kalich BA, Li Y, Rifai A, and Sawlani N

Subjects
lipid-lowering therapy, high-intensity statin, acute coronary syndrome, real-world data, prescribing, adherence, Infectious and parasitic diseases, RC109-216
Abstract

Rasha Khatib,1 Eric J Yeh,2 Nicole Glowacki,1 Catherine B McGuiness,3 Handing Xie,4 Rolin L Wade,4 Bethany A Kalich,5 Yi Li,6 Abdelhadi Rifai,7 Neal Sawlani8 1Academic Research and Strategic Partnership, Advocate Aurora Research Institute, Advocate Aurora Health, Downers Grove, IL, USA; 2Global Health Economics and Outcomes Research (HEOR), Amgen Inc, Thousand Oaks, CA, USA; 3Health Economics and Outcomes Research, Real-World Evidence, IQVIA, Wayne, PA, USA; 4IQVIA, Wayne, PA, USA; 5Amgen Inc, Thousand Oaks, CA, USA; 6R&D Solutions, IQVIA, Bloomington, IL, USA; 7Heart & Vascular Institute, Cheyenne Regional Medical Group, Cheyenne, WY, USA; 8Advocate Lutheran General Hospital, Park Ridge, IL, USACorrespondence: Rasha Khatib, Academic Research and Strategic Partnership, Advocate Aurora Research Institute, Advocate Aurora Health, 3075 Highland Parkway, Suite 600, Downers Grove, IL, 60515, USA, Tel +1 708.684.3691, Email rasha.alkhatib@aah.orgIntroduction: Clinical practice guidelines recommend initiating a high-intensity LLT and continued monitoring of low-density lipoprotein cholesterol (LDL-C) following acute coronary syndrome (ACS). We used real-world data to describe LLT utilization after discharge and 1-year adherence. The reduction in LDL-C was also evaluated.Methods: Data were extracted from electronic health records (EHRs) from 12 hospitals in a large community healthcare system in midwestern United States between 2013 and 2019. Data on eligible patients recently discharged with an ACS event were linked to pharmacy claims data to describe LLT fill rates and 1-year post-discharge adherence. Adherence was reported as the proportion of days covered ≥ 80%.Results: Of the 10,589 eligible patients, 49% filled a high-intensity statin at discharge and only 36% were adherent at 1 year. The mean (SD) age was 66.1± 13.3, 39.3% were females, 58.8% were Caucasian, and 53.0% had Medicare. There was a clear trend for greater fill rates at discharge among patients with higher LDL-C values than those with lower values (p< 0.01). Key predictors of high-intensity (versus medium-intensity) LLT use within 21 days after an ACS event included ACS type (odds ratio [OR] 0.59; 95% confidence interval [CI] 0.52– 0.67 for NSTEMI versus STEMI), age group (OR: 0.59; 95% CI: 0.48– 0.72 for > 75 years versus < 65 years), and statin use before index ACS event (OR: 1.56; 95% CI: 1.23– 1.88).Conclusion: This real-world study found that despite recommendations in clinical practice guidelines, high-intensity LLT fill rates at discharge and 1-year adherence to LLT remain suboptimal. Clinical characteristics, including ACS type and LDL-C values, were strong predictors of filling and adherence to guideline-recommended therapy. Age, sex, and race/ethnicity disparities were observed in discharge fill rates and 1-year adherence. These results highlight the need for continued efforts at the patient and provider levels to improve LLT adherence among ACS patients.Keywords: lipid-lowering therapy, high-intensity statin, acute coronary syndrome, real-world data, prescribing, adherence

Published
2023

3. Patient-reported outcome measures and patient engagement in heart failure clinical trials: multi-stakeholder perspectives

Author

Zannad, F, Alikhaani, J, Alikhaani, S, Butler, J, Gordon, J, Jensen, K, Khatib, R, Mantovani, L, Martinez, R, Moore, W, Murakami, M, Roessig, L, Stockbridge, N, Van Spall, H, Yancy, C, Spertus, J, Zannad F., Alikhaani J., Alikhaani S., Butler J., Gordon J., Jensen K., Khatib R., Mantovani L., Martinez R., Moore W. F., Murakami M., Roessig L., Stockbridge N., Van Spall H. G. C., Yancy C., Spertus J. A., Zannad, F, Alikhaani, J, Alikhaani, S, Butler, J, Gordon, J, Jensen, K, Khatib, R, Mantovani, L, Martinez, R, Moore, W, Murakami, M, Roessig, L, Stockbridge, N, Van Spall, H, Yancy, C, Spertus, J, Zannad F., Alikhaani J., Alikhaani S., Butler J., Gordon J., Jensen K., Khatib R., Mantovani L., Martinez R., Moore W. F., Murakami M., Roessig L., Stockbridge N., Van Spall H. G. C., Yancy C., and Spertus J. A.

Abstract

There are many consequences of heart failure (HF), including symptoms, impaired health-related quality of life (HRQoL), and physical and social limitations (functional status). These have a substantial impact on patients' lives, yet are not routinely captured in clinical trials. Patient-reported outcomes (PROs) can quantify patients' experiences of their disease and its treatment. Steps can be taken to improve the use of PROs in HF trials, in regulatory and payer decisions, and in patient care. Importantly, PRO measures (PROMs) must be developed with involvement of patients, family members, and caregivers from diverse demographic groups and communities. PRO data collection should become more routine not only in clinical trials but also in clinical practice. This may be facilitated by the use of digital tools and interdisciplinary patient advocacy efforts. There is a need for standardization, not only of the PROM instruments, but also in procedures for analysis, interpretation and reporting PRO data. More work needs to be done to determine the degree of change that is important to patients and that is associated with increased risks of clinical events. This ‘minimal clinically important difference’ requires further research to determine thresholds for different PROMs, to assess consistency across trial populations, and to define standards for improvement that warrant regulatory and reimbursement approvals. PROs are a vital part of patient care and drug development, and more work should be done to ensure that these measures are both reflective of the patient experience and that they are more widely employed.

Published
2023

4. Adherence to secondary prevention medicines by coronary heart disease patients : first reported adherence

Author

Khatib, R., Hall, Alistair., Marshall, Kay M., and Silcock, Jonathan

Subjects
615.1, Patient compliance, Concordance, Heart disease, Angina, Self-reported medicines adherence, Medicines adherence assessment, Shared decision making
Abstract

Background Non-adherence to evidence based secondary prevention medicines (SPM) by coronary heart disease (CHD) patients limits their expected benefits and may result in a lack of improvement or significant deterioration in health. This study explored self-reported non-adherence to SPM, barriers to adherence, and the perception that patients in West Yorkshire have about their medicines in order to inform practice and improve adherence. Methods In this cross-sectional study a specially designed postal survey (The Heart Medicines Survey) assessed medicines-taking behaviour using the Morisky Medicines Adherence 8 items Scale (MMAS-8), a modified version of the Single Question Scale (SQ), the Adherence Estimator (AE), Beliefs about Medicines Questionnaire(BMQ) and additional questions to explore practical barriers to adherence. Patients were also asked to make any additional comments about their medicines-taking experience. A purposive sample of 696 patients with long established CHD and who were on SPM for at least 3 months was surveyed. Ethical approval was granted by the local ethics committee. Results 503 (72%) patients participated in the survey. 52%, 34% and 11% of patients were prescribed at least four, three and two SPMs respectively. The level of non-adherence to collective SPM was 44%. The AE predicted that 39% of those had an element of intentional non-adherence. The contribution of aspirin, statins, clopidogrel, beta blockers, angiotensin converting enzyme inhibitors (ACEI) and angiotensin receptor blockers (ARBs) to overall non-adherence as identified by the SQ scale was 62%, 67%, 7%, 30%, 22% and 5%, respectively. A logistic regression model for overall non-adherence revealed that older age and female gender were associated with less non-adherence (OR = 0.96, 95% CI: 0.94, 0.98; OR = 0.56, 95% CI: 0.34, 0.93; respectively). Specific concern about SPM, having issues with repeat prescriptions and aspirin were associated with more non-adherence (OR = 1.12, 95% CI: 1.07, 1.18; OR = 2.48, 95% CI: 1.26, 4.90, OR = 2.22, 95% CI: 1.18, 4.17). Other variables were associated with intentional and non-intentional non-adherence. 221 (44%) patients elaborated on their medicines-taking behaviour by providing additional comments about the need for patient tailored information and better structured medicines reviews. Conclusions The Medicines Heart Survey was successful in revealing the prevalence of self-reported non-adherence and barriers to adherence in our population. Healthcare professionals should examine specific modifiable barriers to adherence in their population before developing interventions to improve adherence. Conducting frequent structured medicines-reviews, which explore and address patients' concerns about their medicines and healthcare services, and enable them to make suggestions, will better inform practice and may improve adherence.

Published
2012

5. Fruit, vegetable, and legume intake, and cardiovascular disease and deaths in 18 countries (PURE): a prospective cohort study

Author

Diaz, R, Orlandini, A, Linetsky, B, Toscanelli, S, Casaccia, G, Cuneo, JM Maini, Rahman, O, Yusuf, R, Azad, AK, Rabbani, KA, Cherry, HM, Mannan, A, Hassan, I, Talukdar, AT, Tooheen, RB, Khan, MU, Sintaha, M, Choudhury, T, Haque, R, Parvin, S, Avezum, A, Oliveira, GB, Marcilio, CS, Mattos, AC, Teo, K, Yusuf, S, Dejesus, J, Agapay, D, Tongana, T, Solano, R, Kay, I, Trottier, S, Rimac, J, Elsheikh, W, Heldman, L, Ramezani, E, Dagenais, G, Poirier, P, Turbide, G, Auger, D, De Bluts, A LeBlanc, Proulx, MC, Cayer, M, Bonneville, N, Lear, S, Gasevic, D, Corber, E, de Jong, V, Vukmirovich, I, Wielgosz, A, Fodor, G, Pipe, A, Shane, A, Lanas, F, Seron, P, Martinez, S, Valdebenito, A, Oliveros, M, Wei, Li, Lisheng, Liu, Chunming, Chen, Xingyu, Wang, Wenhua, Zhao, Hongye, Zhang, Xuan, Jia, Bo, Hu, Yi, Sun, Jian, Bo, Xiuwen, Zhao, Xiaohong, Chang, Tao, Chen, Hui, Chen, Qing, Deng, Xiaoru, Cheng, Xinye, He, Jian, Li, Juan, Li, Xu, Liu, Bing, Ren, Wei, Wang, Yang, Wang, Jun, Yang, Yi, Zhai, Manlu, Zhu, Fanghong, Lu, Jianfang, Wu, Yindong, Li, Yan, Hou, Liangqing, Zhang, Baoxia, Guo, Xiaoyang, Liao, Shiying, Zhang, Rongwen, Bian, Xiuzhen, Tian, Dong, Li, Di, Chen, Jianguo, Wu, Yize, Xiao, Tianlu, Liu, Peng, Zhang, Changlin, Dong, Ning, Li, Xiaolan, Ma, Yuqing, Yang, Rensheng, Lei, Minfan, Fu, Jing, He, Yu, Liu, Xiaojie, Xing, Qiang, Zhou, Lopez-Jaramillo, P, Lopez, PA Camacho, Garcia, R, Jurado, LJA, Gómez-Arbeláez, D, Arguello, JF, Dueñas, R, Silva, S, Pradilla, LP, Ramirez, F, Molina, DI, Cure-Cure, C, Perez, M, Hernandez, E, Arcos, E, Fernandez, S, Narvaez, C, Paez, J, Sotomayor, A, Garcia, H, Sanchez, G, David, T, Rico, A, Mony, P, Vaz, M, Bharathi, A V, Swaminathan, S, Kurpad, K Shankar AV, Jayachitra, KG, Kumar, N, Hospital, HAL, Mohan, V, Deepa, M, Parthiban, K, Anitha, M, Hemavathy, S, Rahulashankiruthiyayan, T, Anitha, D, Sridevi, K, Gupta, R, Panwar, RB, Mohan, I, Rastogi, P, Rastogi, S, Bhargava, R, Kumar, R, Thakur, J S, Patro, B, Lakshmi, PVM, Mahajan, R, Chaudary, P, Kutty, V Raman, Vijayakumar, K, Ajayan, K, Rajasree, G, Renjini, AR, Deepu, A, Sandhya, B, Asha, S, Soumya, HS, Kelishadi, R, Bahonar, A, Mohammadifard, N, Heidari, H, Yusoff, K, Ismail, TST, Ng, KK, Devi, A, Nasir, NM, Yasin, MM, Miskan, M, Rahman, EA, Arsad, MKM, Ariffin, F, Razak, SA, Majid, FA, Bakar, NA, Yacob, MY, Zainon, N, Salleh, R, Ramli, MKA, Halim, NA, Norlizan, SR, Ghazali, NM, Arshad, MN, Razali, R, Ali, S, Othman, HR, Hafar, CWJCW, Pit, A, Danuri, N, Basir, F, Zahari, SNA, Abdullah, H, Arippin, MA, Zakaria, NA, Noorhassim, I, Hasni, MJ, Azmi, MT, Zaleha, MI, Hazdi, KY, Rizam, AR, Sazman, W, Azman, A, Khatib, R, Khammash, U, Khatib, A, Giacaman, R, Iqbal, R, Afridi, A, Khawaja, R, Raza, A, Kazmi, K, Zatonski, W, Szuba, A, Zatonska, K, Ilow, R, Ferus, M, Regulska-Ilow, B, Rózanska, D, Wolyniec, M, Alkamel, Ali, M, Kruger, M A, Voster, H H, Schutte, A E, Wentzel-Viljoen, E, Eloff, FC, de Ridder, H, Moss, H, Potgieter, J, Roux, AA, Watson, M, de Wet, G, Olckers, A, Jerling, JC, Pieters, M, Hoekstra, T, Puoane, T, Igumbor, E, Tsolekile, L, Sanders, D, Naidoo, P, Steyn, N, Peer, N, Mayosi, B, Rayner, B, Lambert, V, Levitt, N, Kolbe-Alexander, T, Ntyintyane, L, Hughes, G, Swart, R, Fourie, J, Muzigaba, M, Xapa, S, Gobile, N, Ndayi, K, Jwili, B, Ndibaza, K, Egbujie, B, Rosengren, A, Boström, K Bengtsson, Gustavsson, A, Andreasson, M, Snällman, M, Wirdemann, L, Oguz, A, Imeryuz, N, Altuntas, Y, Gulec, S, Temizhan, A, Karsidag, K, Calik, KBT, Akalin, AAK, Caklili, OT, Keskinler, MV, Erbakan, AN, Yusufali, AM, Almahmeed, W, Swidan, H, Darwish, EA, Hashemi, ARA, Al-Khaja, N, Muscat-Baron, JM, Ahmed, SH, Mamdouh, TM, Darwish, WM, Abdelmotagali, MHS, Awed, SA Omer, Movahedi, GA, Hussain, F, Al Shaibani, H, Gharabou, RIM, Youssef, DF, Nawati, AZS, Salah, ZAR Abu, Abdalla, RFE, Al Shuwaihi, SM, Al Omairi, MA, Cadigal, OD, Alejandrino, R.S., Chifamba, J, Gwaunza, L, Terera, G, Mahachi, C, Murambiwa, P, Machiweni, T, Mapanga, R, Miller, Victoria, Mente, Andrew, Dehghan, Mahshid, Rangarajan, Sumathy, Zhang, Xiaohe, Swaminathan, Sumathi, Dagenais, Gilles, Gupta, Rajeev, Mohan, Viswanathan, Lear, Scott, Bangdiwala, Shrikant I, Schutte, Aletta E, Wentzel-Viljoen, Edelweiss, Avezum, Alvaro, Altuntas, Yuksel, Yusoff, Khalid, Ismail, Noorhassim, Peer, Nasheeta, Chifamba, Jephat, Diaz, Rafael, Rahman, Omar, Mohammadifard, Noushin, Lana, Fernando, Zatonska, Katarzyna, Wielgosz, Andreas, Yusufali, Afzalhussein, Iqbal, Romaina, Lopez-Jaramillo, Patricio, Khatib, Rasha, Rosengren, Annika, Li, Wei, Liu, Jiankang, Liu, Xiaoyun, Yin, Lu, Teo, Koon, Anand, Sonia, and Yusuf, Salim

Published
2017
Full Text
View/download PDF

6. Associations of fats and carbohydrate intake with cardiovascular disease and mortality in 18 countries from five continents (PURE): a prospective cohort study

Author

Diaz, R, Orlandini, A, Linetsky, B, Toscanelli, S, Casaccia, G, Cuneo, JM Maini, Rahman, O, Yusuf, R, Azad, AK, Rabbani, KA, Cherry, HM, Mannan, A, Hassan, I, Talukdar, AT, Tooheen, RB, Khan, MU, Sintaha, M, Choudhury, T, Haque, R, Parvin, S, Avezum, A, Oliveira, GB, Marcilio, CS, Mattos, AC, Teo, K, Yusuf, S, Dejesus, J, Agapay, D, Tongana, T, Solano, R, Kay, I, Trottier, S, Rimac, J, Elsheikh, W, Heldman, L, Ramezani, E, Dagenais, G, Poirier, P, Turbide, G, Auger, D, De Bluts, A LeBlanc, Proulx, MC, Cayer, M, Bonneville, N, Lear, S, Gasevic, D, Corber, E, de Jong, V, Vukmirovich, I, Wielgosz, A, Fodor, G, Pipe, A, Shane, A, Lanas, F, Seron, P, Martinez, S, Valdebenito, A, Oliveros, M, Wei, Li, Lisheng, Liu, Chunming, Chen, Xingyu, Wang, Wenhua, Zhao, Hongye, Zhang, Xuan, Jia, Bo, Hu, Yi, Sun, Jian, Bo, Xiuwen, Zhao, Xiaohong, Chang, Tao, Chen, Hui, Chen, Qing, Deng, Xiaoru, Cheng, Xinye, He, Jian, Li, Juan, Li, Xu, Liu, Bing, Ren, Wei, Wang, Yang, Wang, Jun, Yang, Yi, Zhai, Manlu, Zhu, Fanghong, Lu, Jianfang, Wu, Yindong, Li, Yan, Hou, Liangqing, Zhang, Baoxia, Guo, Xiaoyang, Liao, Shiying, Zhang, Rongwen, Bian, Xiuzhen, Tian, Dong, Li, Di, Chen, Jianguo, Wu, Yize, Xiao, Tianlu, Liu, Peng, Zhang, Changlin, Dong, Ning, Li, Xiaolan, Ma, Yuqing, Yang, Rensheng, Lei, Minfan, Fu, Jing, He, Yu, Liu, Xiaojie, Xing, Qiang, Zhou, Lopez-Jaramillo, P, Lopez, PA Camacho, Garcia, R, Jurado, LJA, Gómez-Arbeláez, D, Arguello, JF, Dueñas, R, Silva, S, Pradilla, LP, Ramirez, F, Molina, DI, Cure-Cure, C, Perez, M, Hernandez, E, Arcos, E, Fernandez, S, Narvaez, C, Paez, J, Sotomayor, A, Garcia, H, Sanchez, G, David, T, Rico, A, Mony, P, Vaz, M, Bharathi, A V, Swaminathan, S, Kurpad, K Shankar AV, Jayachitra, KG, Kumar, N, Hospital, HAL, Mohan, V, Deepa, M, Parthiban, K, Anitha, M, Hemavathy, S, Rahulashankiruthiyayan, T, Anitha, D, Sridevi, K, Gupta, R, Panwar, RB, Mohan, I, Rastogi, P, Rastogi, S, Bhargava, R, Kumar, R, Thakur, J S, Patro, B, Lakshmi, PVM, Mahajan, R, Chaudary, P, Kutty, V Raman, Vijayakumar, K, Ajayan, K, Rajasree, G, Renjini, AR, Deepu, A, Sandhya, B, Asha, S, Soumya, HS, Kelishadi, R, Bahonar, A, Mohammadifard, N, Heidari, H, Yusoff, K, Ismail, TST, Ng, KK, Devi, A, Nasir, NM, Yasin, MM, Miskan, M, Rahman, EA, Arsad, MKM, Ariffin, F, Razak, SA, Majid, FA, Bakar, NA, Yacob, MY, Zainon, N, Salleh, R, Ramli, MKA, Halim, NA, Norlizan, SR, Ghazali, NM, Arshad, MN, Razali, R, Ali, S, Othman, HR, Hafar, CWJCW, Pit, A, Danuri, N, Basir, F, Zahari, SNA, Abdullah, H, Arippin, MA, Zakaria, NA, Noorhassim, I, Hasni, MJ, Azmi, MT, Zaleha, MI, Hazdi, KY, Rizam, AR, Sazman, W, Azman, A, Khatib, R, Khammash, U, Khatib, A, Giacaman, R, Iqbal, R, Afridi, A, Khawaja, R, Raza, A, Kazmi, K, Zatonski, W, Szuba, A, Zatonska, K, Ilow, R, Ferus, M, Regulska-Ilow, B, Rózanska, D, Wolyniec, M, Alkamel, Ali, M, Kruger, M A, Voster, H H, Schutte, A E, Wentzel-Viljoen, E, Eloff, FC, de Ridder, H, Moss, H, Potgieter, J, Roux, AA, Watson, M, de Wet, G, Olckers, A, Jerling, JC, Pieters, M, Hoekstra, T, Puoane, T, Igumbor, E, Tsolekile, L, Sanders, D, Naidoo, P, Steyn, N, Peer, N, Mayosi, B, Rayner, B, Lambert, V, Levitt, N, Kolbe-Alexander, T, Ntyintyane, L, Hughes, G, Swart, R, Fourie, J, Muzigaba, M, Xapa, S, Gobile, N, Ndayi, K, Jwili, B, Ndibaza, K, Egbujie, B, Rosengren, A, Boström, K Bengtsson, Gustavsson, A, Andreasson, M, Snällman, M, Wirdemann, L, Oguz, A, Imeryuz, N, Altuntas, Y, Gulec, S, Temizhan, A, Karsidag, K, Calik, KBT, Akalin, AAK, Caklili, OT, Keskinler, MV, Erbakan, AN, Yusufali, AM, Almahmeed, W, Swidan, H, Darwish, EA, Hashemi, ARA, Al-Khaja, N, Muscat-Baron, JM, Ahmed, SH, Mamdouh, TM, Darwish, WM, Abdelmotagali, MHS, Awed, SA Omer, Movahedi, GA, Hussain, F, Al Shaibani, H, Gharabou, RIM, Youssef, DF, Nawati, AZS, Salah, ZAR Abu, Abdalla, RFE, Al Shuwaihi, SM, Al Omairi, MA, Cadigal, OD, Alejandrino, R.S., Chifamba, J, Gwaunza, L, Terera, G, Mahachi, C, Murambiwa, P, Machiweni, T, Mapanga, R, Dehghan, Mahshid, Mente, Andrew, Zhang, Xiaohe, Swaminathan, Sumathi, Li, Wei, Mohan, Viswanathan, Iqbal, Romaina, Kumar, Rajesh, Wentzel-Viljoen, Edelweiss, Rosengren, Annika, Amma, Leela Itty, Avezum, Alvaro, Chifamba, Jephat, Diaz, Rafael, Khatib, Rasha, Lear, Scott, Lopez-Jaramillo, Patricio, Liu, Xiaoyun, Gupta, Rajeev, Mohammadifard, Noushin, Gao, Nan, Oguz, Aytekin, Ramli, Anis Safura, Seron, Pamela, Sun, Yi, Szuba, Andrzej, Tsolekile, Lungiswa, Wielgosz, Andreas, Yusuf, Rita, Hussein Yusufali, Afzal, Teo, Koon K, Rangarajan, Sumathy, Dagenais, Gilles, Bangdiwala, Shrikant I, Islam, Shofiqul, Anand, Sonia S, and Yusuf, Salim

Published
2017
Full Text
View/download PDF

7. Association of dietary nutrients with blood lipids and blood pressure in 18 countries: a cross-sectional analysis from the PURE study

Author

Yusuf, S, Rangarajan, S, Teo, K K, Chow, C K, O'Donnell, M, Mente, A, Leong, D, Smyth, A, Joseph, P, Merchant, A, Islam, S, Zhang, M, Hu, W, Ramasundarahettige, C, Wong, G, Bangdiwala, S, Dyal, L, Casanova, A, Dehghan, M, Lewis, G, Aliberti, A, Arshad, A, Reyes, A, Zaki, A, Lewis, B, Zhang, B, Agapay, D, Hari, D, Milazzo, E, Ramezani, E, Hussain, F, Shifaly, F, McAlpine, G, Kay, I, Lindeman, J, Rimac, J, Swallow, J, Heldman, L, Mushtaha, M(a), Mushtaha, M(o), Trottier, M, Riggi, M, Aoucheva, N, Kandy, N, Mackie, P, Solano, R, Chin, S, Ramacham, S, Shahrook, S, Trottier, S, Tongana, T, ElSheikh, W, Iyengar, Y, McQueen, M, Hall, K, Keys, J, Wang, X, Keneth, J, Devanath, A, Diaz, R, Orlandini, A, Linetsky, B, Toscanelli, S, Casaccia, G, Cuneo, JM Maini, Rahman, O, Yusuf, R, Azad, AK, Rabbani, KA, Cherry, HM, Mannan, A, Hassan, I, Talukdar, AT, Tooheen, RB, Khan, MU, Sintaha, M, Choudhury, T, Haque, R, Parvin, S, Avezum, A, Oliveira, GB, Marcilio, CS, Mattos, AC, Teo, K, Dejesus, J, Elsheikh, W, Dagenais, G, Poirier, P, Turbide, G, Auger, D, De Bluts, A LeBlanc, Proulx, MC, Cayer, M, Bonneville, N, Lear, S, Gasevic, D, Corber, E, de Jong, V, Vukmirovich, I, Wielgosz, A, Fodor, G, Pipe, A, Shane, A, Lanas, F, Seron, P, Martinez, S, Valdebenito, A, Oliveros, M, Wei, Li, Lisheng, Liu, Chunming, Chen, Xingyu, Wang, Wenhua, Zhao, Hongye, Zhang, Xuan, Jia, Bo, Hu, Yi, Sun, Jian, Bo, Xiuwen, Zhao, Xiaohong, Chang, Tao, Chen, Hui, Chen, Qing, Deng, Xiaoru, Cheng, Xinye, He, Jian, Li, Juan, Li, Xu, Liu, Bing, Ren, Wei, Wang, Yang, Wang, Jun, Yang, Yi, Zhai, Manlu, Zhu, Fanghong, Lu, Jianfang, Wu, Yindong, Li, Yan, Hou, Liangqing, Zhang, Baoxia, Guo, Xiaoyang, Liao, Shiying, Zhang, Rongwen, Bian, Xiuzhen, Tian, Dong, Li, Di, Chen, Jianguo, Wu, Yize, Xiao, Tianlu, Liu, Peng, Zhang, Changlin, Dong, Ning, Li, Xiaolan, Ma, Yuqing, Yang, Rensheng, Lei, Minfan, Fu, Jing, He, Yu, Liu, Xiaojie, Xing, Qiang, Zhou, Lopez-Jaramillo, P, Lopez, PA Camacho, Garcia, R, Jurado, LJA, Gómez-Arbeláez, D, Arguello, JF, Dueñas, R, Silva, S, Pradilla, LP, Ramirez, F, Molina, DI, Cure-Cure, C, Perez, M, Hernandez, E, Arcos, E, Fernandez, S, Narvaez, C, Paez, J, Sotomayor, A, Garcia, H, Sanchez, G, David, T, Rico, A, Mony, P, Vaz, M, Bharathi, A V, Swaminathan, S, Kurpad, K Shankar AV, Jayachitra, KG, Kumar, N, Hospital, HAL, Mohan, V, Deepa, M, Parthiban, K, Anitha, M, Hemavathy, S, Rahulashankiruthiyayan, T, Anitha, D, Sridevi, K, Gupta, R, Panwar, RB, Mohan, I, Rastogi, P, Rastogi, S, Bhargava, R, Kumar, R, Thakur, J S, Patro, B, Lakshmi, PVM, Mahajan, R, Chaudary, P, Kutty, V Raman, Vijayakumar, K, Ajayan, K, Rajasree, G, Renjini, AR, Deepu, A, Sandhya, B, Asha, S, Soumya, HS, Kelishadi, R, Bahonar, A, Mohammadifard, N, Heidari, H, Yusoff, K, Ismail, TST, Ng, KK, Devi, A, Nasir, NM, Yasin, MM, Miskan, M, Rahman, EA, Arsad, MKM, Ariffin, F, Razak, SA, Majid, FA, Bakar, NA, Yacob, MY, Zainon, N, Salleh, R, Ramli, MKA, Halim, NA, Norlizan, SR, Ghazali, NM, Arshad, MN, Razali, R, Ali, S, Othman, HR, Hafar, CWJCW, Pit, A, Danuri, N, Basir, F, Zahari, SNA, Abdullah, H, Arippin, MA, Zakaria, NA, Noorhassim, I, Hasni, MJ, Azmi, MT, Zaleha, MI, Hazdi, KY, Rizam, AR, Sazman, W, Azman, A, Khatib, R, Khammash, U, Khatib, A, Giacaman, R, Iqbal, R, Afridi, A, Khawaja, R, Raza, A, Kazmi, K, Dans, A, Co, HU, Sanchez, JT, Pudol, L, Zamora-Pudol, C, Palileo-Villanueva, LAM, Aquino, MR, Abaquin, C, Pudol, SL, Cabral, ML, Zatonski, W, Szuba, A, Zatonska, K, Ilow, R, Ferus, M, Regulska-Ilow, B, Rózanska, D, Wolyniec, M, AlHabib, KF, Hersi, A, Kashour, T, Alfaleh, H, Alshamiri, M, Altaradi, HB, Alnobani, O, Bafart, A, Alkamel, N, Ali, M, Abdulrahman, M, Nouri, R, Kruger, A, Voster, H H, Schutte, A E, Wentzel-Viljoen, E, Eloff, FC, de Ridder, H, Moss, H, Potgieter, J, Roux, AA, Watson, M, de Wet, G, Olckers, A, Jerling, JC, Pieters, M, Hoekstra, T, Puoane, T, Igumbor, E, Tsolekile, L, Sanders, D, Naidoo, P, Steyn, N, Peer, N, Mayosi, B, Rayner, B, Lambert, V, Levitt, N, Kolbe-Alexander, T, Ntyintyane, L, Hughes, G, Swart, R, Fourie, J, Muzigaba, M, Xapa, S, Gobile, N, Ndayi, K, Jwili, B, Ndibaza, K, Egbujie, B, Rosengren, A, Bengtsson Boström, K, Gustavsson, A, Andreasson, M, Snällman, M, Wirdemann, L, Yeates, K, Sleeth, J, Kilonzo, K, Oguz, A, Imeryuz, N, Altuntas, Y, Gulec, S, Temizhan, A, Karsidag, K, Calik, KBT, Akalin, AAK, Caklili, OT, Keskinler, MV, Erbakan, AN, Yusufali, AM, Almahmeed, W, Swidan, H, Darwish, EA, Hashemi, ARA, Al-Khaja, N, Muscat-Baron, JM, Ahmed, SH, Mamdouh, TM, Darwish, WM, Abdelmotagali, MHS, Awed, SA Omer, Movahedi, GA, Al Shaibani, H, Gharabou, RIM, Youssef, DF, Nawati, AZS, Salah, ZAR Abu, Abdalla, RFE, Al Shuwaihi, SM, Al Omairi, MA, Cadigal, OD, Alejandrino, R.S., Chifamba, J, Gwaunza, L, Terera, G, Mahachi, C, Murambiwa, P, Machiweni, T, Mapanga, R, Mente, Andrew, Dehghan, Mahshid, Rangarajan, Sumathy, McQueen, Matthew, Dagenais, Gilles, Wielgosz, Andreas, Lear, Scott, Li, Wei, Chen, Hui, Wang, Yang, Diaz, Rafael, Avezum, Alvaro, Lopez-Jaramillo, Patricio, Seron, Pamela, Kumar, Rajesh, Gupta, Rajeev, Mohan, Viswanathan, Swaminathan, Sumathi, Kutty, Raman, Zatonska, Katarzyna, Iqbal, Romaina, Yusuf, Rita, Mohammadifard, Noushin, Khatib, Rasha, Nasir, Nafiza Mat, Ismail, Noorhassim, Oguz, Aytekin, Rosengren, Annika, Yusufali, Afzalhussein, Wentzel-Viljoen, Edelweiss, Puoane, Thandi, Chifamba, Jephat, Teo, Koon, Anand, Sonia S, and Yusuf, Salim

Published
2017
Full Text
View/download PDF

8. Availability and affordability of blood pressure-lowering medicines and the effect on blood pressure control in high-income, middle-income, and low-income countries: an analysis of the PURE study data

Author

Yusuf, S, Rangarajan, S, Teo, K K, Chow, C K, O'Donnell, M, Mente, A, Leong, D, Smyth, A, Joseph, P, Islam, S, Zhang, M, Hu, W, Ramasundarahettige, C, Wong, G, Dayal, L, Casanova, A, Dehghan, M, Lewis, G, Aliberti, A, Reyes, A, Zaki, A, Lewis, B, Zhang, B, Agapay, D, Hari, D, Milazzo, E, Ramezani, E, Hussain, F, Shifaly, F, Kay, I, Rimac, J, Swallow, J, Heldman, L, Mushtaha, M(a), Mushtaha, M(o), Trottier, M, Aoucheva, N, Kandy, N, Mackie, P, Solano, R, Chin, S, Ramacham, S, Shahrook, S, Trottier, S, Tongana, T, ElSheikh, W, Lindeman, J, McQueen, M, Hall, K, Keys, J, Wang, X, Keneth, J, Devanath, A, Diaz, R, Orlandini, A, Linetsky, B, Toscanelli, S, Casaccia, G, Maini Cuneo, JM, Rahman, O, Yusuf, R, Azad, AK, Rabbani, KA, Cherry, HM, Mannan, A, Hassan, I, Talukdar, AT, Tooheen, RB, Khan, MU, Sintaha, M, Choudhury, T, Haque, R, Parvin, S, Avezum, A, Oliveira, GB, Marcilio, CS, Mattos, AC, Teo, K, Dejesus, J, Elsheikh, W, Dagenais, G, Poirier, P, Turbide, G, Auger, D, De Bluts, A LeBlanc, Proulx, MC, Cayer, M, Bonneville, N, Lear, S, Gasevic, D, Corber, E, de Jong, V, Vukmirovich, I, Wielgosz, A, Fodor, G, Pipe, A, Shane, A, Lanas, F, Seron, P, Martinez, S, Valdebenito, A, Oliveros, M, Wei, Li, Lisheng, Liu, Chunming, Chen, Xingyu, Wang, Wenhua, Zhao, Hongye, Zhang, JiaXuan, Bo, Hu, Yi, Sun, Jian, Bo, Xiuwen, Zhao, Xiaohong, Chang, Tao, Chen, Hui, Chen, Qing, Deng, Xiaoru, Cheng, Xinye, He, Jian, Li, Juan, Li, Xu, Liu, Bing, Ren, Wei, Wang, Yang, Wang, Jun, Yang, Yi, Zhai, Manlu, Zhu, Fanghong, Lu, Jianfang, Wu, Yindong, Li, Yan, Hou, Liangqing, Zhang, Baoxia, Guo, Xiaoyang, Liao, Shiying, Zhang, BianRongwen, TianXiuzhen, Dong, Li, Di, Chen, Jianguo, Wu, Yize, Xiao, Tianlu, Liu, Peng, Zhang, Changlin, Dong, Ning, Li, Xiaolan, Ma, Yuqing, Yang, Rensheng, Lei, Minfan, Fu, Jing, He, Yu, Liu, Xiaojie, Xing, Qiang, Zhou, Lopez-Jaramillo, P, Lopez, PA Camacho, Garcia, R, Jurado, LJA, Gómez-Arbeláez, D, Arguello, JF, Dueñas, R, Silva, S, Pradilla, LP, Ramirez, F, Molina, DI, Cure-Cure, C, Perez, M, Hernandez, E, Arcos, E, Fernandez, S, Narvaez, C, Paez, J, Sotomayor, A, Garcia, H, Sanchez, G, David, T, Rico, A, Mony, P, Vaz, M, Bharathi, A V, Swaminathan, S, Shankar, K, Kurpad, AV, Jayachitra, KG, Kumar, N, Hospital, HAL, Mohan, V, Deepa, M, Parthiban, K, Anitha, M, Hemavathy, S, Rahulashankiruthiyayan, T, Anitha, D, Sridevi, K, Gupta, R, Panwar, RB, Mohan, I, Rastogi, P, Rastogi, S, Bhargava, R, Kumar, R, Thakur, J S, Patro, B, Lakshmi, PVM, Mahajan, R, Chaudary, P, Kutty, V Raman, Vijayakumar, K, Ajayan, K, Rajasree, G, Renjini, AR, Deepu, A, Sandhya, B, Asha, S, Soumya, HS, Kelishadi, R, Bahonar, A, Mohammadifard, N, Heidari, H, Yusoff, K, Ismail, TST, Ng, KK, Devi, A, Nasir, NM, Yasin, MM, Miskan, M, Rahman, EA, Arsad, MKM, Ariffin, F, Razak, SA, Majid, FA, Bakar, NA, Yacob, MY, Zainon, N, Salleh, R, Ramli, MKA, Halim, NA, Norlizan, SR, Ghazali, NM, Arshad, MN, Razali, R, Ali, S, Othman, HR, Hafar, CWJCW, Pit, A, Danuri, N, Basir, F, Zahari, SNA, Abdullah, H, Arippin, MA, Zakaria, NA, Noorhassim, I, Hasni, MJ, Azmi, MT, Zaleha, MI, Hazdi, KY, Rizam, AR, Sazman, W, Azman, A, Khatib, R, Khammash, U, Khatib, A, Giacaman, R, Iqbal, R, Afridi, A, Khawaja, R, Raza, A, Kazmi, K, Dans, A, Co, HU, Sanchez, JT, Pudol, L, Zamora-Pudol, C, Palileo-Villanueva, LAM, Aquino, MR, Abaquin, C, Pudol, SL, Cabral, ML, Zatonski, W, Szuba, A, Zatonska, K, Ilow#, R, Ferus, M, Regulska-Ilow, B, Różańska, D, Wolyniec, M, AlHabib, KF, Hersi, A, Kashour, T, Alfaleh, H, Alshamiri, M, Altaradi, HB, Alnobani, O, Bafart, A, Alkamel, N, Ali, M, Abdulrahman, M, Nouri, R, Kruger, A, Voster, H H, Schutte, A E, Wentzel-Viljoen, E, Eloff, FC, de Ridder, H, Moss, H, Potgieter, J, Roux, AA, Watson, M, de Wet, G, Olckers, A, Jerling, JC, Pieters, M, Hoekstra, T, Puoane, T, Igumbor, E, Tsolekile, L, Sanders, D, Naidoo, P, Steyn, N, Peer, N, Mayosi, B, Rayner, B, Lambert, V, Levitt, N, Kolbe-Alexander, T, Ntyintyane, L, Hughes, G, Swart, R, Fourie, J, Muzigaba, M, Xapa, S, Gobile, N, Ndayi, K, Jwili, B, Ndibaza, K, Egbujie, B, Rosengren, A, Boström, K Bengtsson, Lindblad, U, Langkilde, P, Gustavsson, A, Andreasson, M, Snällman, M, Wirdemann, L, Pettersson, K, Moberg, E, Yeates, K, Sleeth, J, Kilonzo, K, Oguz, A, Akalin, AAK, Calik, KBT, Imeryuz, N, Temizhan, A, Alphan, E, Gunes, E, Sur, H, Karsidag, K, Gulec, S, Altuntas, Y, Yusufali, AM, Almahmeed, W, Swidan, H, Darwish, EA, Hashemi, ARA, Al-Khaja, N, Muscat-Baron, JM, Ahmed, SH, Mamdouh, TM, Darwish, WM, Abdelmotagali, MHS, Awed, SA Omer, Movahedi, GA, Shaibani, H Al, Gharabou, RIM, Youssef, DF, Nawati, AZS, Salah, ZAR Abu, Abdalla, RFE, Shuwaihi, SM Al, Omairi, MA Al, Cadigal, OD, Alejandrino, R.S., Chifamba, J, Gwaunza, L, Terera, G, Mahachi, C, Murambiwa, P, Machiweni, T, Mapanga, R, Attaei, Marjan W, Khatib, Rasha, McKee, Martin, Lear, Scott, Dagenais, Gilles, Igumbor, Ehimario U, AlHabib, Khalid F, Kaur, Manmeet, Kruger, Lanthe, Teo, Koon, Lanas, Fernando, Yusoff, Khalid, Oguz, Aytekin, Gupta, Rajeev, Yusufali, Afzalhussein M, Bahonar, Ahmad, Kutty, Raman, Rosengren, Annika, Mohan, Viswanathan, Avezum, Alvaro, Yusuf, Rita, Szuba, Andrzej, Rangarajan, Sumathy, Chow, Clara, and Yusuf, Salim

Published
2017
Full Text
View/download PDF

9. A176 ASSOCIATIONS OF ANTIBIOTICS, HORMONAL THERAPIES, ORAL CONTRACEPTIVES, AND LONG-TERM NSAIDS WITH INFLAMMATORY BOWEL DISEASE: RESULTS FROM THE PROSPECTIVE URBAN RURAL EPIDEMIOLOGY (PURE) STUDY

Author

Pray, C, primary, Narula, N, additional, Wong, E C, additional, Marshall, J K, additional, Rangarajan, S, additional, Islam, S, additional, Bahonar, A, additional, Alhabib, K F, additional, Kontsevaya, A, additional, Ariffin, F, additional, Co, H U, additional, Al Sharief, W, additional, Szuba, A, additional, Wielgosz, A, additional, Diaz, M L, additional, Yusuf, R, additional, Kruger, L, additional, Soman, B, additional, Li, Y, additional, Wang, C, additional, Yin, L, additional, Erkin, M, additional, Lanas, F, additional, Davletov, K, additional, Rosengren, A, additional, Lopez-Jaramillo, P, additional, Khatib, R, additional, Oguz, A, additional, Iqbal, R, additional, Yeates, K, additional, Avezum, Á, additional, Reinisch, W, additional, Moayyedi, P, additional, and Yusuf, S, additional

Published
2023
Full Text
View/download PDF

12. P856 Associations of antibiotics, hormonal therapies, oral contraceptives, and long-term NSAIDs with Inflammatory Bowel Disease: results from the Prospective Urban Rural Epidemiology (PURE) study

Author

Narula, N, primary, Wong, E C L, additional, Pray, C, additional, Marshall, J K, additional, Rangarajan, S, additional, Islam, S, additional, Bahonar, A, additional, Alhabib, K F, additional, Kontsevaya, A, additional, Ariffin, F, additional, Co, H U, additional, Al Sharief, W, additional, Szuba, A, additional, Wielgosz, A, additional, Diaz, M L, additional, Yusuf, R, additional, Kruger, L, additional, Soman, B, additional, Li, Y, additional, Wang, C, additional, Yin, L, additional, Mirrakhimov, E, additional, Lanas, F, additional, Davletov, K, additional, Rosengren, A, additional, Lopez-Jaramillo, P, additional, Khatib, R, additional, Oguz, A, additional, Iqbal, R, additional, Yeates, K, additional, Avezum, Á, additional, Reinisch, W, additional, Moayyedi, P, additional, and Yusuf, S, additional

Published
2023
Full Text
View/download PDF

20. Abstracts

Author

Telenti, A., Marshall, W. F., Proper, J., Aksamit, A. J., Smith, T. F., Matthey, S., Nicholson, D., Ruhs, S., Alden, B., Knock, M., McLean, D. M., McKendall, R. R., Lairmore, M. D., Oas, J., McLinden, J., Stapelton, J., Ploplis, V., Rosen, E., Porter-Jordan, K., Rosenberg, E., Keiser, J., Garrett, C. T., Reyes, M. P., Meriwether, C., Moore, E. C., Philpot, D., Cohen, F., Riepenhoff-Talty, M., Uhnoo, I., Greenberg, H. B., Fisher, J. E., Chegas, P., Barrett, H., Li, P. K., Ogra, P. L., Littlewood, R. A., Sibau, L. E., Sherlock, C. H., Shimozuma, M., Miner, R. C., Epstein, W. L., Drew, W. L., Fukuyama, K., Siegel, C., Johnston, S., Subbarao, E. K., Waner, J. L., Walpita, P., Jalowayski, A., Mason, V., Chadwick, D., Connor, J. D., West, P. G., Baker, W. W., Wiedbrauk, D. L., Welch, K. M., Coffee, S. J., Taylor, A. F., Alexander, R. C., Al-Nakib, W., Yasin, S. R., Tyrrell, D. A. J., Zimmerman, S. J., Moses, E., Sofat, N., Bartholomew, W. R., Amsterdam, D., Gall, D., Reed, C., Crespi, V., Aquino, T. I., Clark, J., Tang, J., Colacino, J. M., Larsen, S. H., Forghani, B., Hurst, M., Chan, C., Dennis, J., Darai, G., Galdiero, F., Folgore, A., Tufano, M. A., Gill, M. J., Cassol, S. A., Gleaves, C. A., Lee, C. F., Rice, D. H., Wendt, S. F., Dobbs, D. R., Meyers, J. D., West, K., Herrmann, J. E., Bruns, M., Ennis, F. A., Khatib, R., Smith, F., Lindquester, G. J., Dambaugh, T., Allen, R., Pellett, P. E., Aarnaes, S. L., MacDonald, R. L., de la Maza, L. M., Peterson, E. M., de la Maza, Luis M., editor, and Peterson, Ellena M., editor

Published
1991
Full Text
View/download PDF

38. Inequalities in the use of secondary prevention of cardiovascular disease by socioeconomic status: evidence from the PURE observational study

Author

Murphy, A. (Adrianna), Palafox, B. (Benjamin), O'Donnell, O.A. (Owen), Stuckler, D. (David), Perel, P. (Pablo), AlHabib, K.F. (Khalid F), Avezum, A. (Alvaro), Bai, X. (Xiulin), Chifamba, J. (Jephat), Chow, C.K. (Clara K), Corsi, D.J. (Daniel J), Dagenais, G.R. (Gilles R), Dans, A.L. (Antonio L), Díaz, R. (Rafael), Erbakan, A.N. (Ayse N), Ismail, N. (Noorhassim), Iqbal, R. (Romaina), Kelishadi, R. (Roya), Khatib, R. (Rasha), Lanas, F. (Fernando), Lear, S.A. (Scott A), Li, W. (Wei), Liu, J. (Jia), Lopez-Jaramillo, P. (Patricio), Mohan, V. (Viswanathan), Monsef, N. (Nahed), Mony, P.K. (Prem K), Puoane, T. (Thandi), Rangarajan, S. (Sumathy), Rosengren, A. (Annika), Schutte, A.E. (Aletta E), Sintaha, M. (Mariz), Teo, K.K. (Koon K), Wielgosz, A. (Andreas), Yeates, K. (Karen), Yin, L. (Lu), Yusoff, K. (Khalid), Zatońska, K. (Katarzyna), Yusuf, S. (Salim), McKee, M. (Martin), Murphy, A. (Adrianna), Palafox, B. (Benjamin), O'Donnell, O.A. (Owen), Stuckler, D. (David), Perel, P. (Pablo), AlHabib, K.F. (Khalid F), Avezum, A. (Alvaro), Bai, X. (Xiulin), Chifamba, J. (Jephat), Chow, C.K. (Clara K), Corsi, D.J. (Daniel J), Dagenais, G.R. (Gilles R), Dans, A.L. (Antonio L), Díaz, R. (Rafael), Erbakan, A.N. (Ayse N), Ismail, N. (Noorhassim), Iqbal, R. (Romaina), Kelishadi, R. (Roya), Khatib, R. (Rasha), Lanas, F. (Fernando), Lear, S.A. (Scott A), Li, W. (Wei), Liu, J. (Jia), Lopez-Jaramillo, P. (Patricio), Mohan, V. (Viswanathan), Monsef, N. (Nahed), Mony, P.K. (Prem K), Puoane, T. (Thandi), Rangarajan, S. (Sumathy), Rosengren, A. (Annika), Schutte, A.E. (Aletta E), Sintaha, M. (Mariz), Teo, K.K. (Koon K), Wielgosz, A. (Andreas), Yeates, K. (Karen), Yin, L. (Lu), Yusoff, K. (Khalid), Zatońska, K. (Katarzyna), Yusuf, S. (Salim), and McKee, M. (Martin)

Abstract

Background: There is little evidence on the use of secondary prevention medicines for cardiovascular disease by socioeconomic groups in countries at different levels of economic development. Methods: We assessed use of antiplatelet, cholesterol, and blood-pressure-lowering drugs in 8492 individuals with self-reported cardiovascular disease from 21 countries enrolled in the Prospective Urban Rural Epidemiology (PURE) study. Defining one or more drugs as a minimal level of secondary prevention, wealth-related inequality was measured using the Wagstaff concentration index, scaled from −1 (pro-poor) to 1 (pro-rich), standardised by age and sex. Correlations between inequalities and national health-related indicators were estimated. Findings: The proportion of patients with cardiovascular disease on three medications ranged from 0% in South Africa (95% CI 0–1·7), Tanzania (0–3·6), and Zimbabwe (0–5·1), to 49·3% in Canada (44·4–54·3). Proportions receiving at least one drug varied from 2·0% (95% CI 0·5–6·9) in Tanzania to 91·4% (86·6–94·6) in Sweden. There was significant (p<0·05) pro-rich inequality in Saudi Arabia, China, Colombia, India, Pakistan, and Zimbabwe. Pro-poor distributions were observed in Sweden, Brazil, Chile, Poland, and the occupied Palestinian territory. The strongest predictors of inequality were public expenditure on health and overall use of secondary prevention medicines. Interpretation: Use of medication for secondary prevention of cardiovascular disease is alarmingly low. In many countries with the lowest use, pro-rich inequality is greatest. Policies associated with an equal or pro-poor distribution include free medications and community health programmes to support adherence to medications. Funding: Full funding sources listed at the end of the paper (see Acknowledgments).

Published
2018
Full Text
View/download PDF

39. Inequalities in the use of secondary prevention of cardiovascular disease by socioeconomic status: evidence from the PURE observational study

Author

Murphy, A, Palafox, B, O'Donnell, Owen, Stuckler, D, Perel, P, AlHabib, KF, Avezum, A, Bai, XL, Chifamba, J, Chow, CK, Corsi, DJ, Dagenais, GR, Dans, AL, Diaz, R, Erbakan, AN, Ismail, N, Iqbal, R, Kelishadi, R, Khatib, R, Lanas, F, Lear, SA, Li, W, Liu, J, Lopez-Jaramillo, P, Mohan, V, Monsef, N, Mony, PK, Puoane, T, Rangarajan, S, Rosengren, A, Schutte, AEM, Sintaha, M, Teo, KK, Wielgosz, A, Yeates, K, Yin, L, Yusoff, K, Zatonska, K, Yusuf, S, McKee, M, Murphy, A, Palafox, B, O'Donnell, Owen, Stuckler, D, Perel, P, AlHabib, KF, Avezum, A, Bai, XL, Chifamba, J, Chow, CK, Corsi, DJ, Dagenais, GR, Dans, AL, Diaz, R, Erbakan, AN, Ismail, N, Iqbal, R, Kelishadi, R, Khatib, R, Lanas, F, Lear, SA, Li, W, Liu, J, Lopez-Jaramillo, P, Mohan, V, Monsef, N, Mony, PK, Puoane, T, Rangarajan, S, Rosengren, A, Schutte, AEM, Sintaha, M, Teo, KK, Wielgosz, A, Yeates, K, Yin, L, Yusoff, K, Zatonska, K, Yusuf, S, and McKee, M

Published
2018

42. Supplemental oxygen and surgical-site infections: an alternating intervention controlled trial

Author

Kurz, A., primary, Kopyeva, T., additional, Suliman, I., additional, Podolyak, A., additional, You, J., additional, Lewis, B., additional, Vlah, C., additional, Khatib, R., additional, Keebler, A., additional, Reigert, R., additional, Seuffert, M., additional, Muzie, L., additional, Drahuschak, S., additional, Gorgun, E., additional, Stocchi, L., additional, Turan, A., additional, and Sessler, D.I., additional

Published
2018
Full Text
View/download PDF

45. Outcome of cholecystectomy in diabetic patients

Author

Ziaee, S., Fanaie, S., Khatib, R., and Khatibzadeh, N.

Subjects
Heart diseases -- Complications and side effects -- Patient outcomes -- Risk factors, Mortality, Diabetes -- Complications and side effects -- Patient outcomes -- Risk factors, Gallstones -- Complications and side effects -- Patient outcomes -- Risk factors, Diabetics -- Patient outcomes, Surgery, Hypertension -- Complications and side effects -- Patient outcomes -- Risk factors, Health, Complications and side effects, Risk factors, Patient outcomes
Abstract

Byline: S. Ziaee, S. Fanaie, R. Khatib, N. Khatibzadeh BACKGROUND : Mortality and morbidity from gallstones in the diabetic patients in comparison with the nondiabetics are always controversial. AIMS : [...]

Published
2005

46. Association of dietary nutrients with blood lipids and blood pressure in 18 countries: a cross-sectional analysis from the PURE study

Author

Mente, Andrew, primary, Dehghan, Mahshid, additional, Rangarajan, Sumathy, additional, McQueen, Matthew, additional, Dagenais, Gilles, additional, Wielgosz, Andreas, additional, Lear, Scott, additional, Li, Wei, additional, Chen, Hui, additional, Yi, Sun, additional, Wang, Yang, additional, Diaz, Rafael, additional, Avezum, Alvaro, additional, Lopez-Jaramillo, Patricio, additional, Seron, Pamela, additional, Kumar, Rajesh, additional, Gupta, Rajeev, additional, Mohan, Viswanathan, additional, Swaminathan, Sumathi, additional, Kutty, Raman, additional, Zatonska, Katarzyna, additional, Iqbal, Romaina, additional, Yusuf, Rita, additional, Mohammadifard, Noushin, additional, Khatib, Rasha, additional, Nasir, Nafiza Mat, additional, Ismail, Noorhassim, additional, Oguz, Aytekin, additional, Rosengren, Annika, additional, Yusufali, Afzalhussein, additional, Wentzel-Viljoen, Edelweiss, additional, Puoane, Thandi, additional, Chifamba, Jephat, additional, Teo, Koon, additional, Anand, Sonia S, additional, Yusuf, Salim, additional, Yusuf, S, additional, Rangarajan, S, additional, Teo, K K, additional, Chow, C K, additional, O'Donnell, M, additional, Mente, A, additional, Leong, D, additional, Smyth, A, additional, Joseph, P, additional, Merchant, A, additional, Islam, S, additional, Zhang, M, additional, Hu, W, additional, Ramasundarahettige, C, additional, Wong, G, additional, Bangdiwala, S, additional, Dyal, L, additional, Casanova, A, additional, Dehghan, M, additional, Lewis, G, additional, Aliberti, A, additional, Arshad, A, additional, Reyes, A, additional, Zaki, A, additional, Lewis, B, additional, Zhang, B, additional, Agapay, D, additional, Hari, D, additional, Milazzo, E, additional, Ramezani, E, additional, Hussain, F, additional, Shifaly, F, additional, McAlpine, G, additional, Kay, I, additional, Lindeman, J, additional, Rimac, J, additional, Swallow, J, additional, Heldman, L, additional, Mushtaha, M(a), additional, Mushtaha, M(o), additional, Trottier, M, additional, Riggi, M, additional, Aoucheva, N, additional, Kandy, N, additional, Mackie, P, additional, Solano, R, additional, Chin, S, additional, Ramacham, S, additional, Shahrook, S, additional, Trottier, S, additional, Tongana, T, additional, ElSheikh, W, additional, Iyengar, Y, additional, McQueen, M, additional, Hall, K, additional, Keys, J, additional, Wang, X, additional, Keneth, J, additional, Devanath, A, additional, Diaz, R, additional, Orlandini, A, additional, Linetsky, B, additional, Toscanelli, S, additional, Casaccia, G, additional, Cuneo, JM Maini, additional, Rahman, O, additional, Yusuf, R, additional, Azad, AK, additional, Rabbani, KA, additional, Cherry, HM, additional, Mannan, A, additional, Hassan, I, additional, Talukdar, AT, additional, Tooheen, RB, additional, Khan, MU, additional, Sintaha, M, additional, Choudhury, T, additional, Haque, R, additional, Parvin, S, additional, Avezum, A, additional, Oliveira, GB, additional, Marcilio, CS, additional, Mattos, AC, additional, Teo, K, additional, Dejesus, J, additional, Elsheikh, W, additional, Dagenais, G, additional, Poirier, P, additional, Turbide, G, additional, Auger, D, additional, De Bluts, A LeBlanc, additional, Proulx, MC, additional, Cayer, M, additional, Bonneville, N, additional, Lear, S, additional, Gasevic, D, additional, Corber, E, additional, de Jong, V, additional, Vukmirovich, I, additional, Wielgosz, A, additional, Fodor, G, additional, Pipe, A, additional, Shane, A, additional, Lanas, F, additional, Seron, P, additional, Martinez, S, additional, Valdebenito, A, additional, Oliveros, M, additional, Wei, Li, additional, Lisheng, Liu, additional, Chunming, Chen, additional, Xingyu, Wang, additional, Wenhua, Zhao, additional, Hongye, Zhang, additional, Xuan, Jia, additional, Bo, Hu, additional, Jian, Bo, additional, Xiuwen, Zhao, additional, Xiaohong, Chang, additional, Tao, Chen, additional, Hui, Chen, additional, Qing, Deng, additional, Xiaoru, Cheng, additional, Xinye, He, additional, Jian, Li, additional, Juan, Li, additional, Xu, Liu, additional, Bing, Ren, additional, Wei, Wang, additional, Yang, Wang, additional, Jun, Yang, additional, Yi, Zhai, additional, Manlu, Zhu, additional, Fanghong, Lu, additional, Jianfang, Wu, additional, Yindong, Li, additional, Yan, Hou, additional, Liangqing, Zhang, additional, Baoxia, Guo, additional, Xiaoyang, Liao, additional, Shiying, Zhang, additional, Rongwen, Bian, additional, Xiuzhen, Tian, additional, Dong, Li, additional, Di, Chen, additional, Jianguo, Wu, additional, Yize, Xiao, additional, Tianlu, Liu, additional, Peng, Zhang, additional, Changlin, Dong, additional, Ning, Li, additional, Xiaolan, Ma, additional, Yuqing, Yang, additional, Rensheng, Lei, additional, Minfan, Fu, additional, Jing, He, additional, Yu, Liu, additional, Xiaojie, Xing, additional, Qiang, Zhou, additional, Lopez-Jaramillo, P, additional, Lopez, PA Camacho, additional, Garcia, R, additional, Jurado, LJA, additional, Gómez-Arbeláez, D, additional, Arguello, JF, additional, Dueñas, R, additional, Silva, S, additional, Pradilla, LP, additional, Ramirez, F, additional, Molina, DI, additional, Cure-Cure, C, additional, Perez, M, additional, Hernandez, E, additional, Arcos, E, additional, Fernandez, S, additional, Narvaez, C, additional, Paez, J, additional, Sotomayor, A, additional, Garcia, H, additional, Sanchez, G, additional, David, T, additional, Rico, A, additional, Mony, P, additional, Vaz, M, additional, Bharathi, A V, additional, Swaminathan, S, additional, Kurpad, K Shankar AV, additional, Jayachitra, KG, additional, Kumar, N, additional, Hospital, HAL, additional, Mohan, V, additional, Deepa, M, additional, Parthiban, K, additional, Anitha, M, additional, Hemavathy, S, additional, Rahulashankiruthiyayan, T, additional, Anitha, D, additional, Sridevi, K, additional, Gupta, R, additional, Panwar, RB, additional, Mohan, I, additional, Rastogi, P, additional, Rastogi, S, additional, Bhargava, R, additional, Kumar, R, additional, Thakur, J S, additional, Patro, B, additional, Lakshmi, PVM, additional, Mahajan, R, additional, Chaudary, P, additional, Kutty, V Raman, additional, Vijayakumar, K, additional, Ajayan, K, additional, Rajasree, G, additional, Renjini, AR, additional, Deepu, A, additional, Sandhya, B, additional, Asha, S, additional, Soumya, HS, additional, Kelishadi, R, additional, Bahonar, A, additional, Mohammadifard, N, additional, Heidari, H, additional, Yusoff, K, additional, Ismail, TST, additional, Ng, KK, additional, Devi, A, additional, Nasir, NM, additional, Yasin, MM, additional, Miskan, M, additional, Rahman, EA, additional, Arsad, MKM, additional, Ariffin, F, additional, Razak, SA, additional, Majid, FA, additional, Bakar, NA, additional, Yacob, MY, additional, Zainon, N, additional, Salleh, R, additional, Ramli, MKA, additional, Halim, NA, additional, Norlizan, SR, additional, Ghazali, NM, additional, Arshad, MN, additional, Razali, R, additional, Ali, S, additional, Othman, HR, additional, Hafar, CWJCW, additional, Pit, A, additional, Danuri, N, additional, Basir, F, additional, Zahari, SNA, additional, Abdullah, H, additional, Arippin, MA, additional, Zakaria, NA, additional, Noorhassim, I, additional, Hasni, MJ, additional, Azmi, MT, additional, Zaleha, MI, additional, Hazdi, KY, additional, Rizam, AR, additional, Sazman, W, additional, Azman, A, additional, Khatib, R, additional, Khammash, U, additional, Khatib, A, additional, Giacaman, R, additional, Iqbal, R, additional, Afridi, A, additional, Khawaja, R, additional, Raza, A, additional, Kazmi, K, additional, Dans, A, additional, Co, HU, additional, Sanchez, JT, additional, Pudol, L, additional, Zamora-Pudol, C, additional, Palileo-Villanueva, LAM, additional, Aquino, MR, additional, Abaquin, C, additional, Pudol, SL, additional, Cabral, ML, additional, Zatonski, W, additional, Szuba, A, additional, Zatonska, K, additional, Ilow, R, additional, Ferus, M, additional, Regulska-Ilow, B, additional, Rózanska, D, additional, Wolyniec, M, additional, AlHabib, KF, additional, Hersi, A, additional, Kashour, T, additional, Alfaleh, H, additional, Alshamiri, M, additional, Altaradi, HB, additional, Alnobani, O, additional, Bafart, A, additional, Alkamel, N, additional, Ali, M, additional, Abdulrahman, M, additional, Nouri, R, additional, Kruger, A, additional, Voster, H H, additional, Schutte, A E, additional, Wentzel-Viljoen, E, additional, Eloff, FC, additional, de Ridder, H, additional, Moss, H, additional, Potgieter, J, additional, Roux, AA, additional, Watson, M, additional, de Wet, G, additional, Olckers, A, additional, Jerling, JC, additional, Pieters, M, additional, Hoekstra, T, additional, Puoane, T, additional, Igumbor, E, additional, Tsolekile, L, additional, Sanders, D, additional, Naidoo, P, additional, Steyn, N, additional, Peer, N, additional, Mayosi, B, additional, Rayner, B, additional, Lambert, V, additional, Levitt, N, additional, Kolbe-Alexander, T, additional, Ntyintyane, L, additional, Hughes, G, additional, Swart, R, additional, Fourie, J, additional, Muzigaba, M, additional, Xapa, S, additional, Gobile, N, additional, Ndayi, K, additional, Jwili, B, additional, Ndibaza, K, additional, Egbujie, B, additional, Rosengren, A, additional, Bengtsson Boström, K, additional, Gustavsson, A, additional, Andreasson, M, additional, Snällman, M, additional, Wirdemann, L, additional, Yeates, K, additional, Sleeth, J, additional, Kilonzo, K, additional, Oguz, A, additional, Imeryuz, N, additional, Altuntas, Y, additional, Gulec, S, additional, Temizhan, A, additional, Karsidag, K, additional, Calik, KBT, additional, Akalin, AAK, additional, Caklili, OT, additional, Keskinler, MV, additional, Erbakan, AN, additional, Yusufali, AM, additional, Almahmeed, W, additional, Swidan, H, additional, Darwish, EA, additional, Hashemi, ARA, additional, Al-Khaja, N, additional, Muscat-Baron, JM, additional, Ahmed, SH, additional, Mamdouh, TM, additional, Darwish, WM, additional, Abdelmotagali, MHS, additional, Awed, SA Omer, additional, Movahedi, GA, additional, Al Shaibani, H, additional, Gharabou, RIM, additional, Youssef, DF, additional, Nawati, AZS, additional, Salah, ZAR Abu, additional, Abdalla, RFE, additional, Al Shuwaihi, SM, additional, Al Omairi, MA, additional, Cadigal, OD, additional, Alejandrino, R.S., additional, Chifamba, J, additional, Gwaunza, L, additional, Terera, G, additional, Mahachi, C, additional, Murambiwa, P, additional, Machiweni, T, additional, and Mapanga, R, additional

Published
2017
Full Text
View/download PDF

48. Refractory pseudofollicular Conjunctivitis

Author

Khatib, R., Goebel, H., Kurschat, C., Roecken, C., Cursiefen, C., Steven, P., Heindl, L. M., Khatib, R., Goebel, H., Kurschat, C., Roecken, C., Cursiefen, C., Steven, P., and Heindl, L. M.

Published
2016

49. A cost effectiveness analysis of salt reduction policies to reduce coronary heart disease in four Eastern Mediterranean countries

Author

Mason, Helen, Shoaibi, Azza, Ghandour, Rula, O'Flaherty, Martin, Capewell, Simon, Khatib, Rana, Jabr, Samer, Unal, Belgin, Sozmen, Kaan, Arfa, Chokri, Aissi, Wafa, Ben Romdhane, Habiba, Fouad, Fouad, Al-Ali, Radwan, Husseini, Abdullatif, Critchley, J., Ahmad, B., Phillimore, P., Zaman, S., Dherani, M., Vartjes, I., Bennett, K., Altun, D., Arik, H., Aslan, O., Demiral, Y., Doganay, S., Ergor, G., Gerceklioglu, G., Kilic, B., Saatli, G., Simsek, H., Satman, I., Gogen, S., Kalaca, S., Elias, M., Rastam, S., Soulaiman, N., Moukeh, G., Maziak, W., Abou Mayaleh, M., Abu-Rmeileh, N., Jaber, S., Khatib, R., Mikki, N., Abu-Kteish, H., Allani, R., Beltaifa, L., Ben Mansour, N., Lassoued, O., Saidi, O., Tlili, F., Achour, N., Ben Salah, N., Collins, M., Roglic, G., Fadhil, I., and Unwin, N.

Subjects
Palestine, Policy Models, economic evaluation, food industry, Turkey, Non-Clinical Medicine, health promotion, Epidemiology, Economics, Cost-Benefit Analysis, Economic Models, Coronary Disease, Coronary Artery Disease, Political Aspects of Health, Cardiovascular, Global Health, Social and Behavioral Sciences, Turkey (republic), Cost Effectiveness, Environmental protection, Health care, Medicine, Socioeconomics, health care economics and organizations, 2. Zero hunger, Multidisciplinary, Cost–benefit analysis, 1. No poverty, blood pressure regulation, health care cost, Cost-effectiveness analysis, salt intake, 3. Good health, Health Education and Awareness, health care policy, Quality-Adjusted Life Years, Public Health, Research Article, Operations Research, Tunisia, Clinical Research Design, Science, Political Science, Cost-Effectiveness Analysis, Public policy, Public Policy, Health Promotion, Syrian Arab Republic, Middle East, Health Economics, food composition, food processing, health education, Humans, Salt intake, Sodium Chloride, Dietary, sodium restriction, Cardiovascular Disease Epidemiology, cost control, Nutrition, Health economics, Health Care Policy, Syria, business.industry, cost effectiveness analysis, Modeling, Health Risk Analysis, ischemic heart disease, Quality-adjusted life year, Economic evaluation, Preventive Medicine, business, food packaging
Abstract

Background: Coronary Heart Disease (CHD) is rising in middle income countries. Population based strategies to reduce specific CHD risk factors have an important role to play in reducing overall CHD mortality. Reducing dietary salt consumption is a potentially cost-effective way to reduce CHD events. This paper presents an economic evaluation of population based salt reduction policies in Tunisia, Syria, Palestine and Turkey. Methods and Findings: Three policies to reduce dietary salt intake were evaluated: a health promotion campaign, labelling of food packaging and mandatory reformulation of salt content in processed food. These were evaluated separately and in combination. Estimates of the effectiveness of salt reduction on blood pressure were based on a literature review. The reduction in mortality was estimated using the IMPACT CHD model specific to that country. Cumulative population health effects were quantified as life years gained (LYG) over a 10 year time frame. The costs of each policy were estimated using evidence from comparable policies and expert opinion including public sector costs and costs to the food industry. Health care costs associated with CHDs were estimated using standardized unit costs. The total cost of implementing each policy was compared against the current baseline (no policy). All costs were calculated using 2010 PPP exchange rates. In all four countries most policies were cost saving compared with the baseline. The combination of all three policies (reducing salt consumption by 30%) resulted in estimated cost savings of $235,000,000 and 6455 LYG in Tunisia; $39,000,000 and 31674 LYG in Syria; $6,000,000 and 2682 LYG in Palestine and $1,3000,000,000 and 378439 LYG in Turkey. Conclusion: Decreasing dietary salt intake will reduce coronary heart disease deaths in the four countries. A comprehensive strategy of health education and food industry actions to label and reduce salt content would save both money and lives. European Community' Seventh Framework Programme (FP7/2007-2013) under grant agreement n223075 the MedCHAMPS project. Scopus

Published
2014

Catalog

Books, media, physical & digital resources
See catalog results